Russian scientists are developing the FIRST drug for melanoma: They plan to complete tests by 2027.
Specialists from Sechenov University are developing the first cell-based drug based on TIL therapy - which uses the patient's own immune cells to fight malignant tumors, for the treatment of melanoma.
TL;DR
- Sechenov University specialists are developing the first cell-based drug using TIL therapy for melanoma treatment.
- TIL therapy utilizes a patient's own immune cells to fight malignant tumors.
- Pre-clinical trials on laboratory animals are planned to begin in 2026 and finish by early 2027.
- The therapy is particularly suited for 'hot' tumors sensitive to immunotherapy, such as melanoma.
- Future plans include adapting this technology for bladder cancer, lung cancer, and other oncological diseases.
- The project is supported by the 'Cell as a Drug' strategic project and the Priority 2030 program.